S'abonner

Influence of Environmental Factors on Prevalence, Symptoms, and Pathologic Process of Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Northwest China - 02/11/11

Doi : 10.1016/j.urology.2011.04.066 
Tian Lan a, Yangmin Wang b, Ye Chen c, Weijun Qin a, Jian Zhang d, Zhipeng Wang e, Wenbin Zhang f, Xianzhi Zhang g, Jianlin Yuan a, He Wang a,
a Department of Urology, Xijing Hospital, Forth Military Medical University, Xi'an, Shaanxi Province, People's Republic of China 
b Department of Urology, Lanzhou General Hospital of Lanzhou Command, Lanzhou, Gansu Province, People's Republic of China 
c Department of Operation and Anesthesiology, Lanzhou General Hospital of Lanzhou Command, Lanzhou, Gansu Province, People's Republic of China 
d Department of Biochemistry and Molecular Biology and State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi'an, Shaanxi Province, People's Republic of China 
e Department of Pharmacology, Fourth Military Medical University School of Pharmacy, Xi'an, Shaanxi Province, People's Republic of China 
f Department of Occupational and Environmental Health, Fourth Military Medical University School of Public Health, Xi'an, Shaanxi Province, People's Republic of China 
g Department of Health Service, Fourth Military Medical University School of Public Health, Xi'an, Shaanxi Province, People's Republic of China 

Reprint requests: He Wang, M.D., Department of Urology, Xijing Hospital, Fourth Military Medical University, 15 Changle West Road, Beilin District, Xi'an 710032 People's Republic of China

Résumé

Objectives

To compare the prevalence, symptoms, and pathologic changes related to chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) with significant prostatitis-like symptoms between 2 altitude areas in northwest China.

Methods

From October 2009 to March 2010 community male residents at 3000 m (Delingha) and 400 m (Xi'An) constituted the population base for the present cross-sectional study. All participants completed a detailed questionnaire containing the National Institutes of Health Chronic Prostatitis Symptom Index, and the subjects who met our definition were invited to undergo clinical evaluation. After screening, the subjects considered to have CP/CPPS were separated into 2 groups: those with type IIIa and those with type IIIb CP/CPPS.

Results

The prevalence of CP/CPPS with significant prostatitis-like symptoms was significantly different between the 2 groups. Moreover, the National Institutes of Health Chronic Prostatitis Symptom Index of patients with type IIIa and IIIb in 2 groups differed significantly, indicating the aggravation of symptoms of CP/CPPS at a high altitude. Additional investigations showed that reactive oxygen species were increased, accompanied by a decrease in the total antioxidant capacity in the expressed prostatic secretions of patients with type IIIa at a higher altitude. In addition, the tumor necrosis factor-⍺, interleukin-8, and interleukin-10 levels in the expressed prostatic secretions of patients with type IIIa in Delingha were increased compared with that in the patients with type IIIa in Xi'An. Notably, the interleukin-6 level in the expressed prostatic secretions was greater in those with type IIIa and IIIb at a higher altitude than in those with type IIIa and IIIb at a low altitude.

Conclusions

At a high altitude, the symptoms of CP/CPPS were aggravated. Oxidative stress and cytokines might involve in the pathologic process and the aggravation of symptoms. In addition, in a high altitude area the pathomechanisms of type IIIa and IIIb CP/CPPS differed.

Le texte complet de cet article est disponible en PDF.

Plan


© 2011  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 78 - N° 5

P. 1142-1149 - novembre 2011 Retour au numéro
Article précédent Article précédent
  • Editorial Comment
  • Tomas L. Griebling
| Article suivant Article suivant
  • Editorial Comment
  • Gilbert J. Wise

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.